Study Indicates Web-Based Tools Can Aid in the Prevention of Major Depressive Disorder | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Study Indicates Web-Based Tools Can Aid in the Prevention of Major Depressive Disorder

May 5, 2016
by Heather Landi
| Reprints
Click To View Gallery

There has been ongoing research and discussion about the use of digital health tools in the treatment of mental health disorders, and also in the prevention of more severe symptoms of those disorders. One study conducted by researchers in Germany and the Netherlands, and published in the Journal of the American Medical Association (JAMA), showed promising results for the use of web-based, guided self-help intervention for the prevention of major depressive disorder (MDD).

According to the researchers, evidence-based treatments for MDD are not very successful in improving functional and health outcomes, and attention has increasingly been focused on the prevention of MDD.

For the study, researchers conducted a randomized clinical trial from March 2013 through March 2015 involved 406 adults with subthreshold depression, or those adults with a Centre for Epidemiologic Studies Depression Scale score greater than or at 16 and no current MDD according to the Diagnostic and Statistical Manual of Mental Disorders.

Study participants were divided into two groups, with both groups having access to usual care, such as visits to a primary care clinician. However, one group also had access to a web-based guided self-help intervention, which involved cognitive-behavioral and problem-solving therapy supported by an online trainer.

The researchers wanted to examine the time to onset of MDD in the intervention group relative to the control group over a 12-month follow-up period.

The results of the 12-month follow-up indicated that 27 percent of the study participants in the intervention group experienced major depressive disorder symptoms compared to 41 percent in the control group.

The researchers concluded that among patients with subthreshold depression, “the use of web-based guided self-help intervention compared with enhanced usual care reduced the incidence of MDD over 12 months.”

However, the researchers also noted that further research is need to examine “whether the effects are generalizable to both first onset of depression and depression recurrence as well as efficacy without the use of an online trainer.”

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.